Supreme Court Unanimously Upholds Patent Rights on Readily Replicable Products

May 15, 2013

Reading Time : 2 min

On Monday, May 13, the Supreme Court unanimously ruled that patent exhaustion does not permit a farmer to make new versions of patented seeds through planting and harvesting purchased seeds without the patent holder’s permission (Bowman v. Monsanto Company et al., No. 11-796; S. Ct.). The decision is a conclusive victory for Monsanto, whose patents on Roundup Ready transgenic seeds have withstood attacks from farmers for more than a decade. 

Monsanto licenses its herbicide resistant soybeans to seed producers who, in turn, sublicense them to farmers under the terms of a licensing agreement. The license limits a farmer’s planting of seeds to a single season, but the Roundup Ready trait is inherited by each successive generation of seed produced by the farmer. Monsanto claimed that farmers, like Indiana soybean farmer Vernon Hugh Bowman, violate the license agreement and infringe Monsanto’s patents by planting second-generation seeds that were either harvested from the original, purchased seeds or purchased as commodity seed from a grain elevator.   

Bowman invoked the defense of patent exhaustion, which traditionally restricts a patent owner’s rights to control the use of a patented product after the first, authorized sale of that particular product into commerce. See Quanta Computer, Inc. v. LG Electronics, Inc., 553 U. S. 617, 625 (2008). The Supreme Court took the case to determine if the patent exhaustion analysis changes in those cases where the patent covers a purportedly “self-replicating product.” The Court ruled, without dissent, that the Patent Act’s traditional protection against unauthorized making of patented articles fully applies to patented products that are self-replicating. The Court further validated the use of license agreements to protect patented products that are susceptible to ready replication, and even holding that license limitations may be implied into a sale. (Slip op. at 6 n.3)

The Court finally noted that “self-replicating product[s] *** are becoming ever more prevalent, complex, and diverse.” (Slip op. at 10) The Court accordingly reserved, for a later day, questions concerning the patent’s protection for “self-replication [that] might occur outside the purchaser’s control” or that “might be a necessary but incidental step in using the item for another purpose.”  Id. In this case, however, “Bowman planted Monsanto’s patented soybeans solely to make and market replicas of them, thus depriving the company of the reward patent law provides for the sale of each article,” and, the Court concluded that “[p]atent exhaustion provides no haven for that conduct.”  Id.

Accordingly, the Supreme Court affirmed the judgment of the Court of Appeals for the Federal Circuit.

Contact Information

If you have any questions regarding this alert, please contact—

Ruthanne M. Deutsch
rmdeutsch@akingump.com
202.887.4081
Washington, D.C.

Emily C. Johnson
johnsone@akingump.com
202.887.4099
Washington, D.C.

Share This Insight

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.